Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Ask Michael Burke -- Ignore unavailable to you. Want to Upgrade?

To: mishedlo who wrote (87474)	12/22/2000 5:51:46 PM
From: Knighty Tin	Read Replies (1) \| Respond to of 132070

Mike, Mea Culpa. I usually write "To All" on these things when I make a portfolio move and didn't do it this time. I can't even blame it on the egg nog, as I am avoiding booze due to being scared to death of getting gout again. Anyway, here is the post, for whatever good that is now: To: ild who wrote (87293) From: Michael D.Burke Wednesday, Dec 20, 2000 12:42 PM ET Reply # of 87475 ild, On the tech side, BEAS, VIGN and QLGC. In biotech, Incy. In closed end funds, ASA and EMF. That's all for today, but more may follow. Anyway, I have punted Beas and Qlgc calls as of today. I will be back in on weakness. I still hold the others. VIGN is doing fine, but hasn't quite hit my short term target yet. Incyte has been laying around not doing anything. ASA and EMF are longer term bets, as closed end funds have to be. They just don't move that awfully fast. However, the options are dirt cheap, so that makes up for glacial movements.